These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12858873)

  • 1. Immunological abnormalities in patients with chronic myeloid leukemia.
    Haematologica; 2003 Jul; 88(7):732. PubMed ID: 12858873
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia.
    Westermann J; Schlimper C; Richter G; Mohm J; Dörken B; Pezzutto A
    Br J Haematol; 2004 Apr; 125(2):213-6. PubMed ID: 15059144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basis of T-cell-mediated immunity to chronic myelogenous leukemia.
    Molldrem JJ; Kant S; Jiang W; Lu S
    Oncogene; 2002 Dec; 21(56):8668-73. PubMed ID: 12476312
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.
    Greiner J; Schmitt M
    Eur J Haematol; 2008 Jun; 80(6):461-8. PubMed ID: 18284627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percentage of CD34 cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count.
    Elliot V; Marin D; Horncastle D; Elderfield K; Apperley JF; Lampert IA; Naresh K
    Br J Haematol; 2005 Aug; 130(3):460-1. PubMed ID: 16042700
    [No Abstract]   [Full Text] [Related]  

  • 6. BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemia.
    Grünebach F; Mirakaj V; Mirakaj V; Müller MR; Brümmendorf T; Brossart P
    Cancer Res; 2006 Jun; 66(11):5892-900. PubMed ID: 16740729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous occurrence of a chronic myeloid leukemia and a malignant T-cell lymphoma.
    Ramji S; Rusia U; Basu TK
    Indian Pediatr; 1988 Jun; 25(6):566-8. PubMed ID: 3266193
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects.
    Butt NM; Rojas JM; Wang L; Christmas SE; Abu-Eisha HM; Clark RE
    Haematologica; 2005 Oct; 90(10):1315-23. PubMed ID: 16219567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia.
    Cervetti G; Carulli G; Galimberti S; Azzarà A; Cannizzo E; Buda G; Orciuolo E; Petrini M
    Leuk Res; 2008 Jan; 32(1):191-2. PubMed ID: 17397920
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute basophilic leukemia arising from chronic myelogenous leukemia with development of t(7;8)(q32;q13).
    Pidala J; Pinilla-Ibarz J; Cualing HD
    Cancer Genet Cytogenet; 2008 Apr; 182(1):46-9. PubMed ID: 18328951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
    Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
    Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
    Pawarode A; Sait SN; Nganga A; Coignet LJ; Barcos M; Baer MR
    Leuk Res; 2007 Nov; 31(11):1589-92. PubMed ID: 17391756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T).
    Gattenlohner S; Völker HU; Etschmann B; Einsele H; Müller-Hermelink HK
    Am J Hematol; 2009 May; 84(5):306-7. PubMed ID: 18951468
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation.
    Orsini E; Calabrese E; Maggio R; Pasquale A; Nanni M; Trasarti S; Tafuri A; Guarini A; Foa R
    Leuk Res; 2006 Jul; 30(7):785-94. PubMed ID: 16527350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination for leukemia.
    Molldrem JJ
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):13-8. PubMed ID: 16399579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor Vbeta repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia.
    Li YQ; Yang LJ; Chen SH; Zhang YP; Zhang XL; Luo GX
    Chin Med J (Engl); 2004 Jun; 117(6):840-3. PubMed ID: 15198883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
    Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
    Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.